OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
CO2 reactivity as a biomarker of exposure-based therapy non-response: study protocol
Jasper A. J. Smits, Marie‐H. Monfils, Michael W. Otto, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Jasper A. J. Smits, Marie‐H. Monfils, Michael W. Otto, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant
Manish K. Jha
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 85-88
Open Access | Times Cited: 6
Manish K. Jha
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 85-88
Open Access | Times Cited: 6
Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114505-114505
Open Access | Times Cited: 3
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114505-114505
Open Access | Times Cited: 3
The role of the peripheral and central adrenergic system in the construction of the subjective emotional experience of panic
Jette H. de Vos, Koen Schruers, Glen Debard, et al.
Psychopharmacology (2024) Vol. 241, Iss. 3, pp. 627-635
Open Access
Jette H. de Vos, Koen Schruers, Glen Debard, et al.
Psychopharmacology (2024) Vol. 241, Iss. 3, pp. 627-635
Open Access
A novel, non-opioid, selective orexin-1 receptor antagonist for the treatment of substance use disorders
Clare Murray, Jennifer Fox, Christian Heidbreder, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104053-104053
Open Access
Clare Murray, Jennifer Fox, Christian Heidbreder, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104053-104053
Open Access
Anxiolytic-like effects of the dual orexin receptor antagonist daridorexant in rats
Michel A. Steiner, R Locher, Hugues Lecourt, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104056-104056
Open Access
Michel A. Steiner, R Locher, Hugues Lecourt, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104056-104056
Open Access
Biochemical challenges for testing novel anti-panic drugs in humans
Kenneth Abrams, Isabel T Folger, Nancy A Cullen, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 242, pp. 173825-173825
Closed Access
Kenneth Abrams, Isabel T Folger, Nancy A Cullen, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 242, pp. 173825-173825
Closed Access
Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers
Sander Brooks, Rob Zuiker, Cathy Bleys, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 6, pp. 577-589
Open Access | Times Cited: 1
Sander Brooks, Rob Zuiker, Cathy Bleys, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 6, pp. 577-589
Open Access | Times Cited: 1
Orexin receptors in GtoPdb v.2023.1
Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design
Uta Lessel, Marco Ferrara, N. Heine, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 12, pp. 5893-5905
Closed Access | Times Cited: 3
Uta Lessel, Marco Ferrara, N. Heine, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 12, pp. 5893-5905
Closed Access | Times Cited: 3
Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinans bearing multiple effective residues (TriMER) library
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
(2021)
Open Access | Times Cited: 2
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
(2021)
Open Access | Times Cited: 2
Evidence-Based Pharmacotherapies for Panic Disorder
Seth D. Norrholm
IntechOpen eBooks (2022)
Open Access | Times Cited: 1
Seth D. Norrholm
IntechOpen eBooks (2022)
Open Access | Times Cited: 1
Anxiolytic-like effects of the dual orexin receptor antagonist daridorexant in rats
R Locher, Hugues Lecourt, François Jenck, et al.
Research Square (Research Square) (2023)
Open Access
R Locher, Hugues Lecourt, François Jenck, et al.
Research Square (Research Square) (2023)
Open Access
The Psychology of Panic
Robert W. Motta, Bhupendra Singh, Olga Lainidi, et al.
IntechOpen eBooks (2022)
Open Access
Robert W. Motta, Bhupendra Singh, Olga Lainidi, et al.
IntechOpen eBooks (2022)
Open Access
CO2 Reactivity as a Biomarker of Exposure-based Therapy Non-Response: Study Protocol
Jasper A. J. Smits, Marie‐H. Monfils, Michael W. Otto, et al.
Research Square (Research Square) (2022)
Open Access
Jasper A. J. Smits, Marie‐H. Monfils, Michael W. Otto, et al.
Research Square (Research Square) (2022)
Open Access
Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinans bearing multiple effective residues (TriMER) library
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
(2021)
Open Access
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, et al.
(2021)
Open Access
